The NanoBiotechnology Group is mainly focused on the use of bioactive molecules and nanoparticles in nanomedicine & nanotechnology. It holds a multidisciplinary philosophy, combining the knowledge of Dr. Alvaro Somoza, an expert in the use of modified oligonucleotides and nanostructures in nanomedicine, and Dr. Begoña Sot, an expert in protein engineering. The group deals with several research lines, centered on the use of modified oligonucleotides and proteins to create new nanomedical tools and sensors.

Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Cantoblanco, 28049 Madrid, Spain & CNB-CSIC-IMDEA Nanociencia Associated Unit “Unidad de Nanobiotecnología”.

IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686)